The global defibrillators market was valued at USD 7.32 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. Several factors are contributing to the rapid expansion of this market, including significant product development efforts, an increasing incidence of sudden cardiac arrest (SCA), heightened awareness about heart health, and ongoing initiatives by governments and healthcare organizations to promote the use of defibrillators in emergency situations.

One of the notable developments in the defibrillator market occurred in May 2021, when Rapid Response Revival Research Ltd., an Australian company, received a CE mark for its innovative CellAED, the world’s first personal automated external defibrillator (AED) designed for home use. This achievement not only marked a significant milestone in the defibrillator market but also supported the company’s growth strategy by expanding the accessibility of defibrillation technology beyond hospitals and emergency services to the general public, especially those in home settings. The introduction of such advanced personal defibrillators is expected to contribute to an increased market share as it helps to improve survival rates for sudden cardiac arrest victims in non-hospital environments.

Another key driver for the defibrillators market is the rising geriatric population globally. As people live longer, the aging population is becoming more susceptible to chronic health conditions, particularly cardiovascular diseases (CVDs). Older individuals, particularly those aged 65 and above, are at higher risk of experiencing cardiac events that require immediate intervention to restore normal heart rhythm. Defibrillators, including implantable cardioverter defibrillators (ICDs) and external AEDs, are crucial for the management of such events, as they can deliver life-saving electric shocks to the heart. 

Gather more insights about the market drivers, restrains and growth of the Defibrillators market

Regional Insights

North America

North America held the largest revenue share of more than 42.1% in 2023 within the defibrillators market, driven by multiple factors including the increasing prevalence of heart diseases, a growing elderly population, a well-established healthcare infrastructure, and the strong presence of industry leaders in the region. Additionally, there is a growing awareness among the public and healthcare professionals regarding the technologies available for treating cardiovascular diseases (CVDs), particularly sudden cardiac arrest (SCA).

For example, the Centers for Disease Control and Prevention (CDC) reported that in 2021, approximately 695,000 deaths in the U.S. were attributed to heart disease, accounting for 1 in every 5 deaths. Furthermore, from 2018 to 2019, the U.S. spent around USD 239.9 billion on heart disease-related healthcare. This increasing incidence of heart-related disorders, paired with technological advancements in defibrillator devices, is driving growth in the region's market. The rising awareness of life-saving treatments like implantable cardioverter-defibrillators (ICDs) and automated external defibrillators (AEDs) further propels this growth.

The U.S. market for defibrillators is particularly strong due to the combination of rising demand from both healthcare providers and patients, as well as government initiatives aimed at improving cardiac care. This has led to innovations in defibrillator technology, making devices more efficient, minimally invasive, and user-friendly. With the ongoing focus on improving cardiac health, the demand for defibrillators in North America is expected to remain robust in the coming years.

Asia Pacific

The Asia Pacific (APAC) region is projected to experience substantial growth in the defibrillators market, driven by a range of socio-economic and health factors. Key contributors to this growth include sedentary lifestyles, unhealthy dietary habits, and an aging population, all of which are leading to a higher incidence of cardiovascular diseases (CVDs). As a result, there is an increasing demand for effective treatment options, such as defibrillators, to address the rising number of cardiovascular incidents.

For instance, a 2022 report on the global burden of cardiovascular diseases revealed that high-income countries in the Asia Pacific region had a CVD mortality rate of 76.6 deaths per 100,000 individuals, while Central Asia recorded a significantly higher rate of 516.9 deaths per 100,000 people. This stark difference highlights the increasing prevalence of CVDs in certain parts of the region, particularly as countries like China, India, and Japan see a rise in lifestyle-related health issues such as obesity and hypertension. Consequently, the demand for defibrillators in Asia Pacific is on the rise, driven by the increased number of cardiology procedures and interventions.

 Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global smart orthopedic implants market size was valued at USD 25.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2030.

• The global implantable cardioverter defibrillators market size was estimated at USD 3.81 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030.

Key Companies & Market Share Insights

The market has been characterized by intense competition. Market players incorporate various strategic initiatives to increase their market share. These include product development, regional expansion, partnerships and collaborations, and mergers & acquisitions. For instance, In August 2022, Medtronic reported the achievement of trial endpoints for its investigational EV ICD (extravascular implantable cardioverter defibrillator) system. This innovative device is designed to mitigate specific risks associated with traditional transvenous ICDs by sitting its lead outside the heart and veins, positioned beneath the sternum, through a minimally invasive approach.

The following companies are leading the charge in the global defibrillators market, driving both technological advancements and market growth:

• Medtronic

• Abbott

• Boston Scientific Corporation

• BIOTRONIK SE & Co. KG

• MicroPort Scientific Corporation

• Koninklijke Philips N.V.

• Stryker

• ZOLL Medical Corporation (Asahi Kasei)

• Nihon Kohden Corporation

• Schiller AG

Order a free sample PDF of the Defibrillators Market Intelligence Study, published by Grand View Research.